Are 30% CAGR PMS Return Claims Realistic? A Reality Check

If you have sat through a PMS pitch in the last three years, you have probably heard some version of "our strategy has compounded at 30% since inception." The number did not come from nowhere. It came from one of the strongest stretches Indian mid- and small-caps have ever had.

Between the pandemic low of March 2020 and the peak of September 2024, broader-market indices roughly tripled, and PMS strategies concentrated in that segment did even better. In the twelve months to August 2024, the average equity PMS strategy returned 40.55%, and the best single strategy in the small-and-mid-cap category returned 98% — figures published by PMS Bazaar, the industry's most widely used performance database. When a year like that sits inside a five- or seven-year track record, it drags the whole CAGR toward the high twenties.

Layer on top of this the way PMS marketing worked until recently: since-inception figures with the inception date chosen by the manager, model-portfolio returns rather than actual client returns, and comparisons against the Nifty 50 price index rather than its total-return version. Put a great year, a favourable start date and a soft benchmark together and a 30% headline writes itself.

None of this means every manager quoting 30% is being dishonest. It means the number needs context that the brochure rarely provides. That is what this reality check is for.

Before checking whether 30% is achievable, it helps to feel how extraordinary it is. Compounding at that rate does not produce a slightly better outcome than a mutual fund; it produces a categorically different one.

At 30% a year, the minimum PMS ticket of ₹50 lakh becomes almost ₹7 crore in a decade and roughly ₹95 crore in two. A 100x multiplier arrives in about 17.5 years. If a manager could reliably deliver this, they would not need your ₹50 lakh; they would be running one of the largest pools of capital on earth within a generation.

This is the first sanity filter. A return that would make a manager richer than the country's largest business houses within thirty years is, by definition, not a base case. It is either a short-window artefact or a claim that will not survive the next full market cycle.

The good news for PMS investors is that the long-run data is respectable. The sobering news is that it is nowhere near 30%.

PMS Bazaar's review of every strategy with at least a ten-year history is the most useful single dataset available. As of February 2024, 53 strategies had a full decade of returns. Their average 10-year CAGR was 18.94%, against 14.73% for the Nifty 50 TRI and 16.7% for the BSE 500 TRI. Forty-one of the 53 — about 77% — beat their benchmark.

Only a few strategies cleared the 30% line: the top performer, Aequitas India Opportunities, was at 36.36%, and the second, Master Trust India Growth Strategy, at 30.08%. The tenth-ranked strategy was in the low twenties. So across the entire population of Indian PMS strategies old enough to judge, roughly two in fifty had compounded at 30% or better over ten years — and both of those were small-cap strategies measured at the top of a small-cap bull market.

The fragility of the headline number shows up the moment the market pauses. In FY24, the average equity PMS strategy returned 46.28%. In FY25, the same universe returned 6.81% — barely ahead of the Nifty 50 TRI at 6.65% — according to PMS Bazaar's FY25 review of 370 strategies. Within the multi-cap and flexi-cap category alone, outcomes ranged from +30.57% to −11% in a single year.

By December 2025, with the Nifty 50 TRI flat for the month, only 30% of the 440 equity strategies tracked managed to beat it, per the December 2025 data. A strategy that quoted a 30% CAGR in mid-2024 has, on average, spent the two years since earning single digits.

The cleanest illustration of end-date sensitivity comes from the very top of the table. The Aequitas strategy showed a ten-year CAGR of 36.36% as of February 2024. In PMS Bazaar's July 2024 ten-year review, the same strategy's ten-year CAGR was 29.58%. Nothing went wrong in between; the ten-year window simply rolled forward five months, dropping a strong stretch from 2014 and picking up a softer one. Same manager, same process, and the "30% CAGR" claim moved by almost seven percentage points on a change of end date alone.

This is the single most important thing to understand about any CAGR: it is a function of two dates, and the person quoting it chose at least one of them.

It is worth stepping back from India for a moment, because the global record sets a ceiling that no marketing deck can argue with.

Berkshire Hathaway's 2025 shareholder letter reports a compounded annual gain of 19.7% in per-share market value from 1965 to 2025, versus 10.5% for the S&P 500 with dividends. That is sixty-one years of the most studied investor in history, and it is not 30%. The overall gain — over six million percent — came from time, not from an outlandish annual rate.

The most famous 30%-class record belongs to Peter Lynch, whose Fidelity Magellan Fund averaged 29.2% a year between May 1977 and May 1990. Two things about it matter. First, it lasted thirteen years, not thirty. Second, Lynch retired at 46, at least partly because he understood the record could not be sustained as the fund grew from $18 million to $14 billion.

Closer to home, the Sensex has a base value of 100 for 1978–79. At its late-September 2026 level of roughly 74,000 — see the Business Standard market close — that works out to a price-only CAGR of about 15% over 47 years, one of the best long-run equity records of any major market. Even the Indian market's entire modern history, dividends excluded, lands at half of 30%.

If the greatest investors and one of the world's best-performing markets compound in the mid-to-high teens over the long run, a 30% forward expectation from a PMS is not conservative, aggressive, or optimistic. It is a different category of claim, and it deserves a different category of scrutiny.

Most exaggerated PMS claims do not involve fabricated numbers. They involve accurate numbers presented without the context that would change how you read them. Here are the seven patterns to watch for.

1. The lucky inception date. A strategy launched in April 2020 or March 2023 has a since-inception CAGR that will look heroic for years. Ask what the return would have been if you had joined at the previous market peak.

2. The model portfolio. Some marketing quotes returns of a paper portfolio or the manager's own account rather than the aggregate of client portfolios. Real client returns are diluted by cash drag, staggered entry and execution costs. SEBI now requires PMS marketing to show the time-weighted rate of return of the actual investment approach, not a model.

3. The soft benchmark. Comparing a small-cap strategy to the Nifty 50, or to a price index instead of a total-return index, adds two to five percentage points of "alpha" that does not exist. The Nifty 50 TRI beat the Nifty 50 price index by roughly the dividend yield every single year.

4. The best-year framing. "Our strategy returned 98% last year" is a fact. It is also a fact that the average equity PMS returned 40% in the same twelve months, and that the same category averaged 11% the following year.

5. Survivorship bias. Strategies that fail are closed, merged or quietly dropped from marketing. The strategies still being sold are, by construction, the ones that worked. Aggregator averages suffer the same bias. Any "average PMS return" you see is an average of survivors.

6. The cherry-picked window. A three-year CAGR ending in September 2024 and a three-year CAGR ending in March 2025 can differ by ten percentage points for the same strategy. Ask for rolling returns, not point-to-point.

7. Gross, not net. The 30% figure is very often before the fixed management fee, before the profit share, before transaction costs and before your capital gains tax. The next section shows how much that matters.

None of these is illegal on its own, and until 2023 most of them were routine. Which is exactly why the regulator stepped in.

The rules on PMS performance disclosure tightened sharply in the last four years, and the requirements are your best friend when evaluating a claim.

SEBI's circular of December 2022, effective 1 April 2023, set out the framework that still applies. As reported by Business Standard, every investment approach must be tagged to one of four strategies — equity, debt, hybrid or multi-asset — and the tag cannot be changed without offering existing clients an exit with no load. The Association of Portfolio Managers in India (APMI) prescribes a maximum of three benchmarks per strategy, and the manager must pick one and stick to it. Critically, any advertisement or marketing material must present the time-weighted rate of return (TWRR) of the investment approach alongside the trailing return of the selected benchmark, and must disclose relative performance against other portfolio managers in the same strategy. Managers report monthly to APMI, which publishes standardised comparisons.

The regulator then followed up on enforcement. In a letter to APMI dated 10 June 2025, SEBI directed portfolio managers to immediately remove "superlative or unsubstantiated" advertisements and claims about past performance, warning that such material creates "a false impression regarding the apparently superior returns" and that enforcement action remained on the table, per Business Standard's report. All advertising must be "factual, verifiable and in strict conformity with the Code of Advertisement" in SEBI's master circular for portfolio managers.

For you as an investor, the practical consequence is simple: any legitimate PMS manager can produce a TWRR-versus-benchmark table for every period, on request, in the APMI format. If a manager cannot or will not, the 30% figure is not one you can rely on. The industry is not small — as of June 2026, PMS managers oversee about ₹43.3 lakh crore, of which roughly ₹5.7 lakh crore is discretionary money from individuals and institutions outside the provident-fund system, according to Business Today — and the disclosure infrastructure now exists to compare it properly.

Suppose, for the sake of argument, a strategy did deliver a genuine 30% gross return in a year. Here is what reaches you.

PMS fee structures vary, but a common one combines a fixed management fee in the region of 2–2.5% of assets with a profit share — often 15–20% of returns above a hurdle rate, typically around 10%, subject to a high-water mark. Take a 2.5% fixed fee and a 20% share above a 10% hurdle as an illustration:

• Gross return: 30.0%
• Less fixed fee: 27.5%
• Less 20% of the 17.5 points above the hurdle: 24.0% net of fees

Transaction costs, custodian and audit charges shave a little more. Then comes tax. Unlike a mutual fund, where the fund's own churn is not a taxable event for you, every sale inside a PMS is taxed in your hands in the year it happens. At the current 12.5% long-term capital gains rate, a fully long-term 24% return becomes roughly 21% post-tax; if a meaningful part of the churn is short-term, the drag is larger.

So a genuine 30% gross year lands closer to 20–21% in your bank account. A genuine 20% gross year — a very good outcome — lands in the mid-teens. This is not an argument against PMS; well-run strategies earn their fees through alpha over a full cycle. It is an argument for asking every manager one question: is this number gross or net, and before or after tax?

Pulling the evidence together, here is a defensible set of expectations for a diversified equity PMS held for a full market cycle of seven to ten years. These are observations from published data, not forecasts, and past performance does not indicate future returns.

The index numbers come from 208 rolling ten-year windows of the Nifty 50 TRI since 1999, which show an average of 14.0%, a low of 6.4% and a high of 22.1%, with no ten-year window ever negative, per the Craytheon rolling-returns dataset built on NSE data. Notice that the index's best ten-year window is 22%. A PMS promising 30% forward is promising to beat the best decade the market has ever had by eight points a year, every year.

Two ways to use this range. First, when a manager quotes a number, place it in the table and ask which row they are really promising. Second, when planning your own goals — retirement corpus, children's education abroad, succession — model the base case, stress-test at the bear case, and treat anything above the strong case as upside you will be glad about but never depend on.

It also helps to remember that the comparison is not PMS versus nothing; it is PMS versus the alternative you would otherwise hold. Over ten years to December 2025, S&P's SPIVA India scorecard found that 76% of active large-cap mutual funds and 79% of mid- and small-cap funds underperformed their benchmarks. Against that backdrop, a PMS that reliably delivers benchmark-plus-two after fees over a decade is a real achievement — and a far more credible pitch than 30%.

You do not need a research team to pressure-test a PMS pitch. You need eight questions and the willingness to walk away if the answers are vague.

1. Is the figure a TWRR of the actual investment approach, or a model portfolio? SEBI requires the former in marketing. Ask for the APMI-format disclosure.

2. What is the benchmark, and is it the total-return version? A small-cap strategy against the Nifty 50 price index is a red flag. The right comparison is the APMI-prescribed benchmark for that strategy, in TRI terms.

3. What are the 1-, 3-, 5- and 10-year returns, and since-inception — and when was inception? A short history starting at a market trough should be weighted accordingly.

4. What do rolling three-year returns look like? Point-to-point CAGR hides variability; rolling returns reveal how often the strategy actually delivered.

5. What was the maximum drawdown, and how long did recovery take? A 30% CAGR strategy with a 55% drawdown is a very different product from a 15% strategy with a 20% drawdown.

6. Is the return gross or net of fees? What is the fee structure — fixed, profit share, hurdle, high-water mark? Get the gross-to-net bridge in writing.

7. How much of the return came from a single year or a single stock? Concentration can flatter a record and can just as easily wreck it.

8. How has AUM changed? Strategies that earned 30% on ₹200 crore often struggle to repeat it on ₹5,000 crore, because the small-cap universe that generated the return cannot absorb the capital.

If a manager answers all eight clearly, you are dealing with a professional, whatever the number turns out to be. If they cannot, the 30% was never the point of the conversation.

Everything above is doable by hand. It is also tedious, error-prone and, when you are comparing five or six strategies, easy to abandon halfway. That gap between what a diligent investor should check and what they actually have time to check is precisely what PMS Sahi Hai was built to close.

PMS Sahi Hai is India's first AI-powered PMS and AIF marketplace, a SEBI-registered distributor tracking over 1,000 PMS and AIF strategies. At its centre is Nyra, your AI Wealth Compass — a companion that turns the fifteen-minute checklist into a few clicks.

When you open the PMS comparison tool, Nyra shows every strategy's returns across standard periods against its category benchmark, so a 30% since-inception number sits next to the three-year and five-year figures that reveal whether it is durable or a single-year artefact. Because Nyra normalises data across managers, you are comparing like with like: the same time windows, the same total-return benchmarks, the same category tags.

Nyra's five-step process starts where good advice should — with your profile and goals, not a product. It then analyses your existing portfolio for hidden overlap, because an investor holding three "30% CAGR" small-cap strategies may in fact own the same forty stocks three times over, tripling concentration risk without tripling diversification. Only then does it surface a curated PMS and AIF match from the strategies that genuinely fit your risk appetite and time horizon, lets you invest directly with India's leading fund managers through the platform, and keeps continuous monitoring in place afterwards, flagging sector shifts, liquidity changes and drawdowns so that a change in a strategy's character shows up on your phone rather than in next year's statement.

If you are new to the category, the What is PMS? guide and the PMS FAQs cover minimum investment, fee structures and taxation in plain language; if you are weighing alternatives, the AIF comparison sits alongside. And when a strategy or a claim needs a human conversation, the team is a message away.

Hard-earned wealth shouldn't rely on random advice — or on a headline CAGR. Nyra helps you see the number in context, and then decide.

A 30% CAGR is a claim. A ten-year, benchmark-relative, net-of-fees record is evidence. Nyra shows you the second so you are never sold on the first.

Compare PMS strategies with Nyra ↗ | Get your PMS Portfolio Health Report ↗